Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus
- Author
- CARNEIRO, J. R. M1 ; SATO, E. I1
[1] Rheumatology Department, Universidade Federal de São Paulo, São Paulo, Brazil - Source
Journal of rheumatology. 1999, Vol 26, Num 6, pp 1275-1279 ; ref : 20 ref
- CODEN
- JRHUA9
- ISSN
- 0315-162X
- Scientific domain
- Rheumatology
- Publisher
- Journal of Rheumatology Publishing, Toronto, ON
- Publication country
- Canada
- Document type
- Article
- Language
- English
- Keyword (fr)
- Chimiothérapie Disséminé Efficacité traitement Essai clinique Etude longitudinale Homme Immunodépresseur Lupus érythémateux Méthotrexate Toxicité Traitement Immunopathologie Maladie autoimmune Maladie système Peau pathologie Tissu conjonctif pathologie
- Keyword (en)
- Chemotherapy Disseminated Treatment efficiency Clinical trial Follow up study Human Immunosuppressive agent Lupus erythematosus Methotrexate Toxicity Treatment Immunopathology Autoimmune disease Systemic disease Skin disease Connective tissue disease
- Keyword (es)
- Quimioterapia Diseminado Eficacia tratamiento Ensayo clínico Estudio longitudinal Hombre Inmunodepresor Lupus eritematoso Metotrexato Toxicidad Tratamiento Inmunopatología Enfermedad autoinmune Enfermedad sistémica Piel patología Tejido conjuntivo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02Q Immunomodulators
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 1842474
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Journal of rheumatology\";s:9:\"\u0000*\u0000stitle\";s:12:\"J. rheumatol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1275\";s:8:\"\u0000*\u0000epage\";s:4:\"1279\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0315-162X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CARNEIRO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"J. R. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:10:\"SATO, E. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JRHUA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:34:\"Journal of Rheumatology Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Journal of rheumatology\";s:9:\"\u0000*\u0000stitle\";s:12:\"J. rheumatol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1275\";s:8:\"\u0000*\u0000epage\";s:4:\"1279\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0315-162X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CARNEIRO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"J. R. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:10:\"SATO, E. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JRHUA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:34:\"Journal of Rheumatology Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Journal of rheumatology\";s:9:\"\u0000*\u0000stitle\";s:12:\"J. rheumatol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1275\";s:8:\"\u0000*\u0000epage\";s:4:\"1279\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0315-162X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CARNEIRO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"J. R. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:10:\"SATO, E. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JRHUA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:34:\"Journal of Rheumatology Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Journal of rheumatology\";s:9:\"\u0000*\u0000stitle\";s:12:\"J. rheumatol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1275\";s:8:\"\u0000*\u0000epage\";s:4:\"1279\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0315-162X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CARNEIRO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"J. R. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:10:\"SATO, E. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JRHUA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:34:\"Journal of Rheumatology Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Journal of rheumatology\";s:9:\"\u0000*\u0000stitle\";s:12:\"J. rheumatol\";s:7:\"\u0000*\u0000date\";s:4:\"1999\";s:9:\"\u0000*\u0000volume\";s:2:\"26\";s:8:\"\u0000*\u0000issue\";s:1:\"6\";s:8:\"\u0000*\u0000spage\";s:4:\"1275\";s:8:\"\u0000*\u0000epage\";s:4:\"1279\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0315-162X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"CARNEIRO\";s:10:\"\u0000*\u0000aufirst\";s:7:\"J. R. M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:1:{i:0;s:10:\"SATO, E. I\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"JRHUA9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:107:\"Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus\";s:8:\"\u0000*\u0000place\";s:11:\"Toronto, ON\";s:6:\"\u0000*\u0000pub\";s:34:\"Journal of Rheumatology Publishing\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
